Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Erdkamp
Safety and Efficacy of the Addition of Simvastatin to Cetuximab in Previously Treated KRAS Mutant Metastatic Colorectal Cancer Patients
Investigational New Drugs
Oncology
Pharmacology
Related publications
PTEN Loss of Expression Predicts Cetuximab Efficacy in Metastatic Colorectal Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
New Strategies for Treatment of KRAS Mutant Metastatic Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
P16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients With Metastatic Colorectal Cancer
Cancer Research and Treatment
Cancer Research
Oncology
KRAS Mutant Allele-Specific Imbalance (MASI) Assessment in Routine Samples of Patients With Metastatic Colorectal Cancer
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer
JAMA Oncology
Cancer Research
Oncology
Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
Farmeconomia. Health economics and therapeutic pathways
Let-7 miRNA-binding Site Polymorphism in the KRAS 3′UTR; Colorectal Cancer Screening Population Prevalence and Influence on Clinical Outcome in Patients With Metastatic Colorectal Cancer Treated With 5-Fluorouracil and Oxaliplatin +/− Cetuximab
BMC Cancer
Cancer Research
Oncology
Genetics
Safety of Nivolumab Plus Low‐Dose Ipilimumab in Previously Treated Microsatellite Instability‐High/Mismatch Repair‐Deficient Metastatic Colorectal Cancer
Oncologist
Cancer Research
Medicine
Oncology
Phase II Study of Gefitinib, Fluorouracil, Leucovorin, and Oxaliplatin Therapy in Previously Treated Patients With Metastatic Colorectal Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
